Lymphoplasmacyte-rich meningioma in the central nervous system: An unusual case report

Han Wang1,2, Bin He3, Yuelong Wang1

  • 1Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, PR China.

Medicine
|December 30, 2021
PubMed

Insights

This study reports a rare case of lymphoplasmacyte-rich meningioma (LPRM) extending from the skull base to the cervical spine. While surgery is standard, immunotherapy may offer new treatment options for this aggressive tumor.

Area of Science:

  • Neuro-oncology
  • Pathology
  • Neurosurgery

Background:

  • Lymphoplasmacyte-rich meningioma (LPRM) is a rare WHO grade I central nervous system tumor.
  • LPRM is characterized by significant infiltration of plasma cells and lymphocytes.
  • This variant presents unique challenges due to its cellular composition and potential for extensive dural involvement.

Observation:

  • A 44-year-old male presented with progressive limb weakness, hand numbness, sensory disturbances, and incontinence.
  • MRI revealed an extensive extramedullary mass encasing the clivus and cervical spinal meninges.
  • Histopathology confirmed LPRM with significant lymphoplasmacytic infiltration.

Findings:

  • Surgical resection via suboccipital craniotomy and extensive spinal decompression was performed.
  • Despite treatment, the patient succumbed to complications of pneumonia two weeks post-surgery.

Implications:

  • This case highlights an exceptionally extensive LPRM involving both intracranial and spinal meninges.
  • The lymphoplasmacytic nature of LPRM suggests potential efficacy of immunotherapy as a future treatment strategy.
Abstract